238 related articles for article (PubMed ID: 6580841)
21. Vindesine. A phase II trial in advanced breast cancer patients.
Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
[TBL] [Abstract][Full Text] [Related]
22. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
[TBL] [Abstract][Full Text] [Related]
23. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B.
Ettinger LJ; Brecher M; Coleman M; Smithson WA; Patterson R; Russell EC; Necheles T; Jones B; Ohnuma T
Med Pediatr Oncol; 1982; 10(1):35-43. PubMed ID: 7038420
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of vindesine in patients with metastatic breast cancer.
Cobleigh MA; Williams SD; Einhorn LH
Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
[TBL] [Abstract][Full Text] [Related]
25. [Phase II study of etoposide (VP-16) in the form of intravenous injection for malignant lymphomas and acute leukemias: Hanshin Cooperative Study Group for Hematological Disorders].
Tagawa S; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H
Gan No Rinsho; 1987 Jan; 33(1):1-7. PubMed ID: 3469424
[TBL] [Abstract][Full Text] [Related]
26. [Vindesine, a new cytostatic agent from the vinca alkaloids].
Goldhirsch A; Joss R; Sonntag RW; Brunner KW
Dtsch Med Wochenschr; 1980 Jun; 105(26):931-5. PubMed ID: 6931709
[No Abstract] [Full Text] [Related]
27. Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignancies.
Ferrazzi E; Pappagallo GL; Segati R; Vinante O; Galligioni E; Zagonel V; Salvagno L; Fiorentino MV
Tumori; 1982 Aug; 68(4):321-4. PubMed ID: 7147357
[TBL] [Abstract][Full Text] [Related]
28. Broad phase II study of vindesine.
Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
[TBL] [Abstract][Full Text] [Related]
29. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
[TBL] [Abstract][Full Text] [Related]
30. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
31. Vindesine in the treatment of malignant mesothelioma: a phase II study.
Kelsen D; Gralla R; Cheng E; Martini N
Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
[TBL] [Abstract][Full Text] [Related]
32. Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion.
Ohnuma T; Greenspan EM; Holland JF
Cancer Treat Rep; 1980 Jan; 64(1):25-30. PubMed ID: 6929728
[TBL] [Abstract][Full Text] [Related]
33. Vindesine for metastatic malignant melanoma. A phase II trial.
Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
[TBL] [Abstract][Full Text] [Related]
34. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study.
Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K
Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659
[TBL] [Abstract][Full Text] [Related]
35. [Phase-II-study with vindesine (desacetyl-vinblastine-amide-sulfate) in advanced malignant diseases].
Goldhirsch A; Beer M; Sonntag RW; Tschopp L; Cavalli F; Ryssel HJ; Brunner KW
Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1063-7. PubMed ID: 7423151
[TBL] [Abstract][Full Text] [Related]
36. [A presumed transient hemolytic reaction following vinca alkaloids administration in patients with hematological malignancies].
Iwata N; Wakamatsu E; Oike S; Umegae S; Omine M; Maekawa T; Tsuchiya J
Rinsho Ketsueki; 1984 May; 25(5):649-54. PubMed ID: 6590896
[No Abstract] [Full Text] [Related]
37. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
[TBL] [Abstract][Full Text] [Related]
38. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of vindesine in advanced head and neck cancer.
Cheng E; Young CW; Wittes RE
Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
[TBL] [Abstract][Full Text] [Related]
40. [Early phase II trial of bestrabucil in hematological malignancies].
Nagura E; Ohno R; Yamada K; Akao Y; Naito K; Nishikawa M; Tanaka H; Shirakawa S; Ono Y; Ezaki K
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2216-22. PubMed ID: 3459398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
